Rockwell CE et al. |
Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2. |
2006 |
Mol. Pharmacol. |
pmid:16611855
|
Szabo B et al. |
Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. |
2006 |
J. Physiol. (Lond.) |
pmid:16973696
|
Kasai HF et al. |
Studies on high-energy collision-induced dissociation of endogenous cannabinoids: 2-arachidonoylglycerol and n-arachidonoylethanolamide in FAB-mass spectrometry. |
2006 |
Anal Sci |
pmid:16837740
|
Mechoulam R et al. |
Endocannabinoids, feeding and suckling--from our perspective. |
2006 |
Int J Obes (Lond) |
pmid:16570101
|
Matias I et al. |
Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. |
2006 |
Int J Obes (Lond) |
pmid:16570107
|
Bari M et al. |
New insights into endocannabinoid degradation and its therapeutic potential. |
2006 |
Mini Rev Med Chem |
pmid:16515464
|
Matias I et al. |
Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration. |
2006 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:17011761
|
Bari M et al. |
Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells. |
2006 |
J. Immunol. |
pmid:17015679
|
Spoto B et al. |
Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol. |
2006 |
Biochimie |
pmid:16949718
|
Gough NR |
Focus issue: signaling lipids. |
2006 |
Sci. STKE |
pmid:16467192
|
Wagner JA et al. |
2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts. |
2006 |
J. Cardiovasc. Pharmacol. |
pmid:16775503
|
Quistad GB et al. |
Monoacylglycerol lipase inhibition by organophosphorus compounds leads to elevation of brain 2-arachidonoylglycerol and the associated hypomotility in mice. |
2006 |
Toxicol. Appl. Pharmacol. |
pmid:16310817
|
van der Stelt M et al. |
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. |
2006 |
Cell. Mol. Life Sci. |
pmid:16732431
|
Panikashvili D et al. |
The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. |
2006 |
Neurobiol. Dis. |
pmid:16364651
|
Parkkari T et al. |
Synthesis and CB1 receptor activities of dimethylheptyl derivatives of 2-arachidonoyl glycerol (2-AG) and 2-arachidonyl glyceryl ether (2-AGE). |
2006 |
Bioorg. Med. Chem. |
pmid:16403642
|
Parkkari T et al. |
Alpha-methylated derivatives of 2-arachidonoyl glycerol: synthesis, CB1 receptor activity, and enzymatic stability. |
2006 |
Bioorg. Med. Chem. Lett. |
pmid:16466915
|
Kurihara R et al. |
Effects of peripheral cannabinoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils. |
2006 |
J. Biol. Chem. |
pmid:16513651
|
Mestre L et al. |
The synthetic cannabinoid WIN 55,212-2 increases COX-2 expression and PGE2 release in murine brain-derived endothelial cells following Theiler's virus infection. |
2006 |
Biochem. Pharmacol. |
pmid:16914119
|
Blüher M et al. |
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. |
2006 |
Diabetes |
pmid:17065342
|
Oka S et al. |
Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice. |
2006 |
J. Immunol. |
pmid:17142782
|